Ameriprise Financial, Inc.
AMP · NYSE
| Reporting period ended | 9/30/2025 Q3 2025 | 6/30/2025 Q2 2025 | 3/31/2025 Q1 2025 | 12/31/2024 Q4 2024 |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.00 | 0.15 | -0.45 | 0.11 |
| FCF Yield | 4.57% | 3.32% | 3.46% | 0.62% |
| EV / EBITDA | 34.52 | 0.00 | 0.00 | 0.00 |
| Quality | ||||
| ROIC | 0.51% | 0.69% | 0.72% | 0.75% |
| Gross Margin | 52.46% | 57.39% | 54.16% | 58.70% |
| Cash Conversion Ratio | 2.42 | 1.66 | 2.89 | 0.36 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.76% | 9.67% | 9.65% | 10.07% |
| Free Cash Flow Growth | 25.14% | 4.61% | 407.69% | -89.16% |
| Safety | ||||
| Net Debt / EBITDA | -3.08 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 15.34 | 19.88 | 18.89 | 22.31 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 278.33 | 179.48 | 197.43 | 154.01 |